JNJ vs ZBH
By Alex · Tickerpine
Johnson & Johnson vs Zimmer Biomet Holdings, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | ZBH |
|---|---|---|
| Price | $285.75 | $103.21 |
| Market cap | $687.89B | $19.53B |
| P/E ratio | 43.4 | 26.1 |
| ROE | 20.02% | 6.03% |
| Profit margin | 16.20% | 8.95% |
| Revenue growth | 5.90% | 3.10% |
| Dividend yield | 1.88% | 0.93% |
| Beta | 0.20 | 0.47 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs ZBH in plain English
- JNJ is the bigger company — about 35.2× the market cap of ZBH.
- ZBH is cheaper on earnings (P/E 26.1 vs 43.4).
- JNJ earns a higher return on equity (20% vs 6%).
- JNJ is growing revenue faster (6% vs 3%).
- JNJ has the higher dividend yield (1.88% vs 0.93%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
ZBH return calculator
See what $1,000 in Zimmer Biomet Holdings, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.